➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Johnson and Johnson
Harvard Business School
McKesson

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

PRASUGREL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Prasugrel, and when can generic versions of Prasugrel launch?

Prasugrel is a drug marketed by Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Hec Pharm, Mylan, Panacea Biotec Ltd, and Uspharma Windlas. and is included in seven NDAs.

The generic ingredient in PRASUGREL is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

US Patents and Regulatory Information for PRASUGREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare PRASUGREL prasugrel hydrochloride TABLET;ORAL 205987-001 Feb 2, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Hec Pharm PRASUGREL prasugrel hydrochloride TABLET;ORAL 206021-001 Jan 16, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms PRASUGREL prasugrel hydrochloride TABLET;ORAL 205913-002 Jun 19, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Panacea Biotec Ltd PRASUGREL prasugrel hydrochloride TABLET;ORAL 205897-002 Oct 16, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Hec Pharm PRASUGREL prasugrel hydrochloride TABLET;ORAL 206021-002 Jan 16, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Uspharma Windlas PRASUGREL prasugrel hydrochloride TABLET;ORAL 205790-002 Oct 16, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Johnson and Johnson
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.